Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Brainstorm Cell Therapeutics

Youtube Subscribe

...

Ticker: BCLI

Sector: Biotechnology

Brainstorm Cell Therapeutics Inc. engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. NurOwn is developing NurOwn, which has completed Phase III clinical trial for the.
...
...
Extended Summary

Brainstorm Cell Therapeutics

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Related Results

...
October 23, 2023 13:19 (London Time)

Brainstorm Cell Therapeutics

Retail investors are its largest shareholders with 59% ownership. Brainstorm Cell Therapeutics, Inc. (NASDAQ:BCLI) Is Expected To Breakeven In The N…
Sector: Biotechnology
Ticker: BCLI
Sentiment: 0.5267
MarketCap: 7,877,765.0
High: 0.2 Low: 0.17

Open: 0.2 Close: 0.18 Change: -0.02

Read more →
...
August 05, 2023 21:47 (London Time)

Brainstorm Cell Therapeutics

BrainStorm Cell Therapeutics is developing innovative, autologous stem cell therapies for neurodegenerative diseases such as Amyotrophic Lateral Scl…
Sector: Biotechnology
Ticker: BCLI
Sentiment: 0.4404
MarketCap: 75,624,939.0
High: 1.74 Low: 1.64

Open: 1.69 Close: 1.66 Change: -0.03

Read more →
...
May 04, 2023 0:25 (London Time)

Brainstorm Cell Therapeutics

Brainstorm Cell Therapeutics Inc. (bCLI) - 1.20% $101.54B Recently Viewed Symbol % Chg Price Overview Company & People Financials Research & Ratings…
Sector: Biotechnology
Ticker: BCLI
Sentiment: 0.5574
MarketCap: 113,017,824
High: 3.2 Low: 3.0

Open: 3.0 Close: 3.08 Change: 0.08

Read more →
...
September 29, 2023 12:45 (London Time)

Brainstorm Cell Therapeutics

US FDA panel votes against BrainStorms ALS therapy over effectiveness concern. US FDA Panel votes against brainstorm Cell Therapeutics therapy over …
Sector: Biotechnology
Ticker: BCLI
Sentiment: 0.34
MarketCap: 9,223,737.0
High: 0.22 Low: 0.17

Open: 0.2 Close: 0.2 Change: 0.0

Read more →
...
May 15, 2023 13:32 (London Time)

Brainstorm Cell Therapeutics

Brainstorm Cell Therapeutics (NASDAQ:BCLI – Get Rating ) last issued its quarterly earnings results on Thursday. The firm has a 50 day moving averag…
Sector: Biotechnology
Ticker: BCLI
Sentiment: 0.836
MarketCap: 96,455,910.0
High: 2.89 Low: 2.75

Open: 2.87 Close: 2.76 Change: -0.11

Read more →
Search
Happening Now
Categories